期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 206, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jpba.2021.114368
关键词
Therapeutic nucleic acids; HPLC; CGE; ELISA
资金
- National Natural Science Foundation of China [81973281]
- Fundamental Research Funds for the Central Universities [2019FZA7017]
Therapeutic nucleic acids, chemically modified RNA or DNA, target pathogenic genes accurately and have wide application prospects. 17 nucleic acid based therapeutics have been approved by FDA or EMA, raising higher requirements for analytical methods. This review introduces different classes of therapeutic nucleic acids, commercialized therapeutics, and analytical methods for nucleic acid based therapeutics.
Therapeutic nucleic acids are various chemically modified RNA or DNA with different functions, which mainly play roles at the gene level. Owing to its accurately targeting at pathogenic genes, nucleic acid based therapeutics have a wide range of application prospects. Recently, the improvement on chemical synthesis and delivery materials accelerated the development of therapeutic nucleic acids rapidly. Up to now, 17 nucleic acid based therapeutics approved by Food and Drug Administration (FDA) or European Medicines Agency (EMA). The development of therapeutics raised higher requirements for analytical methods, both in quality control and in clinical research. The first part of this review introduces different classes of therapeutic nucleic acids, including antisense oligonucleotide (ASO), RNA interference (RNAi) therapy, mRNA, aptamer and other classes which are under research. The second part reviews the therapeutic nucleic acids commercialized from 2019 to now. The third part discusses the analytical methods for nucleic acid based therapeutics, including liquid chromatography-based methods, capillary gel electrophoresis (CGE), hybridization enzyme-linked immunosorbent assay (ELISA) and other infrequently used methods. Finally, the advantages and shortcomings of these methods are summarized, and the future development of analysis methods are prospected. (c) 2021 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据